PTHG2 Reduces Bone Loss in Ovariectomized Mice by Directing Bone Marrow Mesenchymal Stem Cell Fate
Teriparatide, also known as 1-34 parathyroid hormone (PTH (1-34)), is commonly used for the treatment of osteoporosis in postmenopausal women. But its therapeutic application is restricted by poor metabolic stability, low bioavailability, and rapid clearance. Herein, PTHG2, a glycosylated teriparati...
Saved in:
| Main Authors: | Jiao Chen, Hao Zhang, Xianmin Wu, Fuxiao Wang, Yili Wang, Qianmin Gao, Han Liu, Yan Hu, Jiacan Su, Yingying Jing |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2021/8546739 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cell Fate and Differentiation of Bone Marrow Mesenchymal Stem Cells
by: Shoichiro Kokabu, et al.
Published: (2016-01-01) -
Selective Pyk2 inhibition enhances bone restoration through SCARA5-mediated bone marrow remodeling in ovariectomized mice
by: Yunqing Liu, et al.
Published: (2024-11-01) -
Naked cuticle homolog 2 controls the differentiation of osteoblasts and osteoclasts and ameliorates bone loss in ovariectomized mice
by: Liying Shan, et al.
Published: (2025-01-01) -
Targeted inhibition of ferroptosis in bone marrow mesenchymal stem cells by engineered exosomes alleviates bone loss in smoking-related osteoporosis
by: Yao Wang, et al.
Published: (2025-04-01) -
Bone marrow mesenchymal stem cells overexpressing stromal cell- derived factor 1 aid in bone formation in osteoporotic mice
by: Yanghao Wang, et al.
Published: (2024-11-01)